Molina Healthcare (NYSE:MOH) Sees Strong Trading Volume - What's Next?

Key Points

• Molina Healthcare experienced a significant trading volume with around 769,936 shares traded recently, down 11% from the previous day, while the share price rose to $162.04.
• Multiple analysts downgraded their ratings for Molina Healthcare, including Morgan Stanley, which reduced its target from $364.00 to $266.00, while Truist Financial lowered its target from $335.00 to $180.00.
• The company reported a net income margin of 2.60% with a revenue increase of 15.7% from the same quarter last year, generating $11.43 billion against analyst expectations.
• Insider transactions show CEO Joseph M. Zubretsky sold 87,500 shares at an average price of $320.06, reflecting a 25.35% decrease in his ownership in the company.

Shares of Molina Healthcare, Inc (NYSE:MOH - Get Free Report) saw strong trading volume on Friday . 769,936 shares were traded during trading, a decline of 11% from the previous session's volume of 863,914 shares.The stock last traded at $162.04 and had previously closed at $158.22.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on MOH shares. Cantor Fitzgerald reissued a "neutral" rating and set a $210.00 price objective (down from $312.00) on shares of Molina Healthcare in a report on Friday. Truist Financial reissued a "hold" rating and set a $180.00 price objective (down from $335.00) on shares of Molina Healthcare in a report on Friday. JPMorgan Chase & Co. decreased their target price on shares of Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a research report on Tuesday. Wells Fargo & Company decreased their price objective on shares of Molina Healthcare from $372.00 to $216.00 and set an "overweight" rating for the company in a research report on Wednesday, July 23rd. Finally, Mizuho dropped their price objective on shares of Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a research note on Friday, July 11th. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Molina Healthcare currently has a consensus rating of "Hold" and a consensus target price of $253.58.

Molina Healthcare Stock Performance

The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The stock's fifty day moving average is $264.16 and its two-hundred day moving average is $295.30. The firm has a market cap of $8.69 billion, a price-to-earnings ratio of 7.85, a PEG ratio of 4.56 and a beta of 0.55.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The business had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. During the same quarter last year, the business posted $5.86 EPS. The business's revenue for the quarter was up 15.7% on a year-over-year basis. On average, analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer owned 257,715 shares in the company, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.26% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Rothschild Investment LLC raised its holdings in shares of Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after buying an additional 48 shares during the last quarter. Zions Bancorporation National Association UT acquired a new position in shares of Molina Healthcare in the 1st quarter valued at approximately $29,000. Colonial Trust Co SC grew its position in shares of Molina Healthcare by 930.0% in the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock valued at $30,000 after purchasing an additional 93 shares during the period. Deseret Mutual Benefit Administrators lifted its stake in Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after acquiring an additional 34 shares in the last quarter. Finally, Elequin Capital LP raised its stake in shares of Molina Healthcare by 170.6% during the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock worth $30,000 after purchasing an additional 58 shares in the last quarter. 98.50% of the stock is owned by institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.